First Global Reiterates ST Market Perform on Teva Pharmaceutical

First Global reiterated its ST Market Perform rating on Teva Pharmaceutical TEVA. On Wednesday, Teva added 0.14% to its value to end the day at $48.99.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: ReiterationAnalyst RatingsFirst GlobalHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!